Amgen Inc. (AMGN) Balance Sheet
As of 2026-06-30 (10-Q), Amgen Inc. (AMGN) reported total assets of $95.6B and shareholders' equity of $11.7B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $14.0B. Long-term debt: $51.9B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMGNAmgen Inc.Follow AMGN — free
—
Price chart with a free account
- Market cap
- 237.5B
- P/E TTM
- 27.3
- Dividend yield
- 2.3%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.88 | 3.29 | 6.95 | 3.26 | 3.81 | 3.73 | 4.14 | 3.24 | 3.80 | 6.95 | 6.04 | 6.27 | 7.99 | 7.63 | 10.94 | 11.97 | 9.13 | 13.99 | |
| Short-term investments | 10.56 | 14.14 | 13.70 | 20.80 | 15.60 | 23.30 | 27.24 | 34.84 | 37.88 | 22.36 | 2.87 | 4.38 | 0.05 | 1.68 | 0.00 | — | — | — | |
| Receivables | 2.11 | 2.34 | 2.90 | 2.52 | 2.70 | 2.55 | 3.00 | 3.17 | 3.24 | 3.58 | 4.06 | 4.53 | 4.90 | 5.56 | 7.27 | 6.78 | 9.57 | 10.23 | |
| Inventory | 2.22 | 2.02 | 2.48 | 2.74 | 3.02 | 2.65 | 2.44 | 2.75 | 2.83 | 2.94 | 3.58 | 3.89 | 4.09 | 4.93 | 9.52 | 7.00 | 6.23 | 6.22 | |
| Current assets | 18.93 | 23.13 | 27.59 | 31.21 | 27.37 | 34.71 | 38.52 | 46.01 | 49.48 | 37.62 | 18.44 | 21.14 | 19.39 | 22.19 | 30.33 | 29.03 | 29.06 | 34.96 | |
| Total assets | 39.63 | 43.49 | 48.87 | 54.30 | 66.13 | 69.01 | 71.45 | 77.63 | 79.95 | 66.42 | 59.71 | 62.95 | 61.17 | 65.12 | 97.15 | 91.84 | 90.59 | 95.64 | |
| Current liabilities | 3.87 | 6.57 | 5.75 | 8.19 | 7.95 | 7.01 | 8.66 | 11.20 | 9.02 | 13.49 | 12.84 | 11.65 | 12.18 | 15.69 | 18.39 | 23.10 | 25.49 | 25.50 | |
| Long-term debt | 10.60 | 13.36 | 21.43 | 26.53 | 32.13 | 30.72 | 31.43 | 34.60 | 35.34 | 33.93 | 29.90 | 32.99 | 33.31 | 37.35 | 63.17 | 56.55 | 50.01 | 51.86 | |
| Short-term debt | — | 0.00 | — | — | 2.51 | 0.50 | 2.25 | 4.40 | 1.15 | 4.42 | 2.95 | 0.09 | 0.09 | 1.59 | 1.44 | 3.55 | 4.60 | 5.45 | |
| Shareholders' equity | 22.67 | 23.94 | 19.03 | 19.06 | 22.10 | 25.78 | 28.08 | 29.88 | 25.24 | 12.50 | 9.67 | 9.41 | 6.70 | 3.66 | 6.23 | 5.88 | 8.66 | 11.69 |
USD billions · SEC XBRL
Amgen Inc. — questions
- How much cash does Amgen Inc. have?
- $14.0B in cash and cash equivalents as of 2026-06-30.
- How much debt does Amgen Inc. have?
- $51.9B of long-term debt and $5.4B due within a year as of 2026-06-30.
- What are Amgen Inc.'s total assets?
- $95.6B as of 2026-06-30.
- What is Amgen Inc.'s shareholders' equity?
- $11.7B as of 2026-06-30.
Every figure on this page comes from Amgen Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.